PATENT CLAIM ANALYSIS

Application Number: 15867313
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "093700"]

Abstract:
Modulation of the ADAMTS1 signaling pathway alters the commitment of progenitor cells to a muscle fate; and increases muscle mass.

Claim (Index 2):
The method of  claim 1 , wherein the active fragment of human ADAMTS1 protein comprises the polypeptide of SEQ ID NO:4.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.15789
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14442704', '15241523', '11078899', '14384514', '12094585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6684802239915827
- 35 USC 102 Novelty (BERT): 0.5863301531698923
- Combined Prediction Score: 0.6602652169094138
- Mean Citation Score: 271.594316
- Max Citation Score: 487.32446
- Similarity Product: 404.7198883223009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test